scPharmaceuticals Inc. (SCPH) Tops Q1 EPS by 6c

scPharmaceuticals Inc. (NASDAQ: SCPH) reported Q1 EPS of ($0.36), $0.06 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $6.1 million versus the consensus estimate of $5.9 million.

For earnings history and earnings-related data on scPharmaceuticals Inc. (SCPH) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• Papa Johns names interim CFO as Ravi Thanawala departs
• Oppenheimer turns cautious on major U.S. banks, favors alternative asset managers